Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's DiseaseTiago F. Outeiro, Aleksey Kazantsev, Jean‐Christophe Rochet et al.|Science|2007Cited by 1.1k
Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington’s and Parkinson’s diseasesRuth A. Bodner, Aleksey Kazantsev, Tiago F. Outeiro et al.|Proceedings of the National Academy of Sciences|2006Cited by 258
SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease ModelsLuisa Quinti, Aleksey Kazantsev|Cell chemical biology|2016Cited by 87